Problems in spinal mobility are common in people living with ankylosing spondylitis (AS) for more than 10 years, a…
Articles by Ana Pena, PhD
Having ankylosing spondylitis more than doubles the risk of developing depression, and the presence of additional chronic conditions exacerbates…
Reducing the dose of TNF blockers by about half is nearly as effective as the standard dose taken by ankylosing…
Anti-TNF alpha therapy is able to significantly restore ankylosing spondylitis patients’ capacity to exercise after a treatment period…
Filgotinib, an investigational therapy for ankylosing spondylitis,…
Higher levels of fatigue are related to the degree of disability at work among ankylosing…
Women with ankylosing spondylitis (AS) report more severe disease and a poorer quality of life than men, but…
A mutation considered to be a risk factor for…
Male sex, older age at diagnosis, and the presence of certain symptoms are all risk factors for overall…
Therapy with anti-tumor necrosis factor (anti-TNF) is highly effective in people with ankylosing spondylitis. But researchers suggest…